302 related articles for article (PubMed ID: 34203269)
1. Next-Generation Biomarkers for Cholangiocarcinoma.
Rodrigues PM; Vogel A; Arrese M; Balderramo DC; Valle JW; Banales JM
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203269
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic biomarkers in cholangiocarcinoma.
Macias RIR; Kornek M; Rodrigues PM; Paiva NA; Castro RE; Urban S; Pereira SP; Cadamuro M; Rupp C; Loosen SH; Luedde T; Banales JM
Liver Int; 2019 May; 39 Suppl 1():108-122. PubMed ID: 30843325
[TBL] [Abstract][Full Text] [Related]
3. Current omics-based biomarkers for cholangiocarcinoma.
Intuyod K; Armartmuntree N; Jusakul A; Sakonsinsiri C; Thanan R; Pinlaor S
Expert Rev Mol Diagn; 2019 Nov; 19(11):997-1005. PubMed ID: 31566016
[No Abstract] [Full Text] [Related]
4. The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.
Macias RIR; Banales JM; Sangro B; Muntané J; Avila MA; Lozano E; Perugorria MJ; Padillo FJ; Bujanda L; Marin JJG
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1468-1477. PubMed ID: 28782657
[TBL] [Abstract][Full Text] [Related]
5. An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma.
Seeree P; Pearngam P; Kumkate S; Janvilisri T
Int J Genomics; 2015; 2015():179528. PubMed ID: 26421274
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma.
Loosen SH; Roderburg C; Kauertz KL; Pombeiro I; Leyh C; Benz F; Vucur M; Longerich T; Koch A; Braunschweig T; Ulmer TF; Heidenhain C; Tacke F; Binnebösel M; Schmeding M; Trautwein C; Neumann UP; Luedde T
J Hepatol; 2017 Oct; 67(4):749-757. PubMed ID: 28668580
[TBL] [Abstract][Full Text] [Related]
7. Circulating Biomarkers for Cholangiocarcinoma.
Loosen SH; Vucur M; Trautwein C; Roderburg C; Luedde T
Dig Dis; 2018; 36(4):281-288. PubMed ID: 29807369
[TBL] [Abstract][Full Text] [Related]
8. Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance.
Ehlken H; Zenouzi R; Schramm C
Curr Opin Gastroenterol; 2017 Mar; 33(2):78-84. PubMed ID: 28146445
[TBL] [Abstract][Full Text] [Related]
9. Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis.
Lapitz A; Arbelaiz A; O'Rourke CJ; Lavin JL; Casta A; Ibarra C; Jimeno JP; Santos-Laso A; Izquierdo-Sanchez L; Krawczyk M; Perugorria MJ; Jimenez-Aguero R; Sanchez-Campos A; Riaño I; Gónzalez E; Lammert F; Marzioni M; Macias RIR; Marin JJG; Karlsen TH; Bujanda L; Falcón-Pérez JM; Andersen JB; Aransay AM; Rodrigues PM; Banales JM
Cells; 2020 Mar; 9(3):. PubMed ID: 32183400
[No Abstract] [Full Text] [Related]
10. Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications.
Berretta M; Cavaliere C; Alessandrini L; Stanzione B; Facchini G; Balestreri L; Perin T; Canzonieri V
Oncotarget; 2017 Feb; 8(8):14192-14220. PubMed ID: 28077782
[TBL] [Abstract][Full Text] [Related]
11. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis.
Rahnemai-Azar AA; Weisbrod A; Dillhoff M; Schmidt C; Pawlik TM
Surg Oncol; 2017 Jun; 26(2):125-137. PubMed ID: 28577718
[TBL] [Abstract][Full Text] [Related]
12. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
[TBL] [Abstract][Full Text] [Related]
13. Cancer review: Cholangiocarcinoma.
Ghouri YA; Mian I; Blechacz B
J Carcinog; 2015; 14():1. PubMed ID: 25788866
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.
Bao F; Liu J; Chen H; Miao L; Xu Z; Zhang G
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010914
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic serum marker of cholangiocarcinoma (Review).
Zeng X; Tao H
Oncol Lett; 2015 Jan; 9(1):3-8. PubMed ID: 25435926
[TBL] [Abstract][Full Text] [Related]
17. Serum Levels of Cytokine-Induced Apoptosis Inhibitor 1 (CIAPIN1) as a Potential Prognostic Biomarker of Cholangiocarcinoma.
Truong SDA; Tummanatsakun D; Proungvitaya T; Limpaiboon T; Wongwattanakul M; Chua-On D; Roytrakul S; Proungvitaya S
Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34201138
[TBL] [Abstract][Full Text] [Related]
18. Current status of liver transplantation for cholangiocarcinoma.
Goldaracena N; Gorgen A; Sapisochin G
Liver Transpl; 2018 Feb; 24(2):294-303. PubMed ID: 29024405
[TBL] [Abstract][Full Text] [Related]
19. Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile.
Wang B; Chen L; Chang HT
Biomark Med; 2016 Jun; 10(6):613-9. PubMed ID: 27232281
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms.
Kimawaha P; Jusakul A; Junsawang P; Thanan R; Titapun A; Khuntikeo N; Techasen A
Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33806004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
